CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Linguamatics Ltd, a leader in enterprise text mining for the life science and other markets, today announced that Novo Nordisk, a world-leader in diabetes care, has entered into a multi-year agreement to use the I2E semantic knowledge discovery platform for text mining. At Novo Nordisk I2E will be used to mine published literature and internal information sources to provide business critical intelligence for R&D decision makers. Financial details of the agreement were not disclosed.
